Company facts
- Headquarters
- Cheung Sha Wan, Kowloon
- Most recent report
- 6-K, filed Sep 11, 2026
- Filings on record
- 103 filings
- On EDGAR
- CIK 1897532
- Filer status
- Non-accelerated filer, Emerging growth company
Financials 8 of 18
- 6-K Report a foreign issuer made public elsewhere Sep 11, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 7, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 22, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 20, 2026
- 6-K Report a foreign issuer made public elsewhere May 27, 2026
- 6-K Report a foreign issuer made public elsewhere Mar 19, 2026
- 6-K Report a foreign issuer made public elsewhere Mar 9, 2026
- 6-K Report a foreign issuer made public elsewhere Feb 12, 2026
Prospectuses and Registrations 8 of 9
- F-1 Registration statement, foreign issuer Feb 13, 2026
- S-8 Registration statement for an employee plan Nov 12, 2025
- 424B3 Prospectus supplement for an offering Jul 21, 2025
- 424B4 Final prospectus for an offering Jul 21, 2025
- FWP Free writing prospectus Jul 11, 2025
- FWP Free writing prospectus Mar 18, 2025
- F-1 Registration statement, foreign issuer Oct 4, 2024
- FWP Free writing prospectus Feb 20, 2024
Ownership 5
Other 8 of 71
- EFFECT Notice that a registration became effective Feb 26, 2026
- CORRESP Reply to SEC staff Feb 24, 2026
- UPLOAD Comment letter from SEC staff Feb 20, 2026
- CERT Exchange certified a listing Jul 15, 2025
- 8-A12B Registration of a security for exchange listing Jul 15, 2025
- EFFECT Notice that a registration became effective Jun 30, 2025
- CORRESP Reply to SEC staff Jun 27, 2025
- CORRESP Reply to SEC staff Jun 27, 2025
Everything here comes from Ping An Biomedical Co., Ltd.'s own filings on SEC EDGAR. The filing list is rechecked every hour.